A new study says cancer surgery performed at a medical center designated by the National Cancer Institute (NCI) as a "center of excellence" is associated with less risk of death soon after surgery than if performed at a high-volume surgery center, but finds no difference in five-year survival rates.
The full study will be published in the February 1, 2005 issue of CANCER, a peer-reviewed journal of the American Cancer Society. This study was supported by grants from the NCI and the Agency for Healthcare Research and Quality (AHRQ).
In 1971 the NCI created a program to award cancer centers special designation as centers of regional excellence if they demonstrated excellence in three areas: research, cancer prevention, and clinical services. NCI cancer centers are well staffed with specialists, tend to have high procedure volumes, and better access to multidisciplinary consultation and the latest therapies--all reasons to believe they would have better outcomes than other cancer centers. Although these centers often advertise their superior outcomes, say the study's authors, to date their relative performance has not been examined.
Nancy J. O. Birkmeyer, Ph.D. from the Department of Surgery at the University of Michigan Medical School and her colleagues investigated whether this designation actually improves survival. The investigators reviewed data from 63,860 cancer patients who underwent cancer surgery. Patients treated at one of the 51 NCI cancer centers were compared to those from 51 control cancer centers with the highest volumes for each procedure.